drugset
drugset / Trial / NCT03210389

A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.

NCT03210389 ↗

Phase 2 Unknown 60 enrolled Sun Yat-sen University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of chemotherapy with Lobaplatin and 5-FU, in Recurrent Local or Distant Advanced Nasopharyngeal Carcinoma.

Timeline

Start
2017-07
Primary completion
2019-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lobaplatin Small molecule 30 mg/m2 —
Subject fluorouracil Small molecule 0.5 g —

Indications

nasopharyngeal carcinoma